Guselkumab and Risankizumab for Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Guselkumab and Risankizumab for Psoriasis: A 44-Week Indirect Real-Life Comparison
J Am Acad Dermatol 2021 Mar 21;[EPub Ahead of Print], A Ruggiero, G Fabbrocini, E Cinelli, M MegnaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.